News
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
The Supervisory Board of Bayer AG has appointed Dr. Judith Hartmann to the company’s Board of Management, effective March 1, 2026. She will succeed Wolfgang Nickl as the company’s Chief Financial
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc.. (“Tvardi” or the “Company”) (NASDAQ: TVRD).
Faruqi & Faruqi is a
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at VFC
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC).
Faruqi & Faruqi is a leading
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Savara
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA).
Faruqi & Faruqi is a leading
Fuller, Smith & Turner PLC: Transaction in own shares
Funding Circle Holdings plc: POS-Transaction in Own Shares
Intuit’s All-in-One Agentic AI-Driven Consumer Platform Powers Year-Round Money Outcomes for Those Who Need It Most
Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, announced today new AI and Agentic AI experiences across
VICI Properties Inc. Announces $1.16 Billion Sale-Leaseback Transaction With Golden Entertainment
VICI Properties Inc. (NYSE: VICI) (“VICI Properties”, “VICI” or the “Company”) announced today that it has entered into an agreement to acquire 100% of the land, real property and improvements of
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from
Amphenol Corporation Closes Trexon Acquisition
Amphenol Corporation (NYSE: APH) today announced that it has completed its previously announced acquisition of Trexon from Audax Private Equity for approximately $1 billion in cash.
“We are
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc
Form 8.3 - The Vanguard Group, Inc.: Petershill Partners plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: Just Group plc
Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc